Hans‐Georg Eichler
Impact in
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Statistics and Probability top 1%
- Statistical Methods in Clinical Trials
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 40
- Pharmaceutical Economics and Policy 25
-
- Statistical Methods in Clinical Trials 8
- Advanced Causal Inference Techniques 6
- Co-authors
- Panagiotis MavrosSheldon X. KongBengt JönssonWilliam C. GerthGuido RasiOlga GelingAlasdair BreckenridgeHubert G. M. Leufkens
- Journals
- Clinical Pharmacology & Therapeutics (15 papers)Nature Reviews Drug Discovery (15 papers)New England Journal of Medicine (5 papers)European Journal of Clinical Pharmacology (4 papers)Value in Health (4 papers)
- Partner nations
- AustriaNetherlandsUnited Kingdom
In The Last Decade
Hans‐Georg Eichler
86 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Economics and Econometrics 1.5k
- Statistics and Probability 424
- Toxicology 103
- Geriatrics and Gerontology 115
- Ophthalmology 245
Countries citing papers authored by Hans‐Georg Eichler
This map shows the geographic impact of Hans‐Georg Eichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Georg Eichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Georg Eichler more than expected).
Fields of papers citing papers by Hans‐Georg Eichler
This network shows the impact of papers produced by Hans‐Georg Eichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Georg Eichler. The network helps show where Hans‐Georg Eichler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans‐Georg Eichler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2018 | 6 | |
| 3 | 2017 | 1 | |
| 4 | Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making Hit paper breakdown → | 2017 | 327 |
| 5 | 2016 | 35 | |
| 6 | 2016 | 9 | |
| 7 | 2014 | 33 | |
| 8 | 2013 | 68 | |
| 9 | 2013 | 3 | |
| 10 | 2013 | 28 | |
| 11 | 2012 | 92 | |
| 12 | 2011 | 237 | |
| 13 | 2011 | 18 | |
| 14 | 2010 | 104 | |
| 15 | 2010 | 26 | |
| 16 | 2005 | 11 | |
| 17 | 2004 | 113 | |
| 18 | 2004 | 238 | |
| 19 | 1999 | 24 | |
| 20 | 1995 | 10 |
About Hans‐Georg Eichler
Hans‐Georg Eichler is a scholar working on Economics and Econometrics, Statistics and Probability, Pharmacology, Family Practice and Pediatrics, Perinatology and Child Health, having authored 88 papers that have together received 4.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (40 papers), Pharmaceutical Economics and Policy (25 papers), Pharmaceutical studies and practices (15 papers), Biomedical Ethics and Regulation (9 papers), Statistical Methods in Clinical Trials (8 papers), Glaucoma and retinal disorders (6 papers), Advanced Causal Inference Techniques (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). The work is most often cited by research in Economics and Econometrics (1.5k citations), Statistics and Probability (424 citations), Toxicology (103 citations), Geriatrics and Gerontology (115 citations) and Ophthalmology (245 citations). Hans‐Georg Eichler has collaborated with scholars based in Austria, Netherlands and United Kingdom. Frequent co-authors include Panagiotis Mavros, Sheldon X. Kong, Bengt Jönsson, William C. Gerth, Guido Rasi, Olga Geling, Alasdair Breckenridge, Hubert G. M. Leufkens, Éric Abadie and Bruno Flamion. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Nature Reviews Drug Discovery, New England Journal of Medicine, European Journal of Clinical Pharmacology and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.